Clinical trial-Efficacy and safety of biapenem in elderly respiratory tract infection-

Clinical trial-Efficacy and safety of biapenem in elderly respiratory tract infection- - Clinical trial-Efficacy and safety of biapenem in elderly respiratory tract infection-

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005046

Enrollment

Registered

2011-02-15

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly respiratory tract infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 elderly people over 65 years old the case fulfilling all under points two days before from starting of administration 2 a body temperature higher than 37 degrees C 3 CRP higher than 1.0mg per dl 4 evidence of pneumonia in the chest radiography or chest CT 5 purulent sputum

Exclusion criteria

Exclusion criteria: 1 under severe heart damage under severe liver damage under severe kidney damage 2 under many combination drug therapy 3 beta lactam agent allergy 4 pregnant female 5 atypical pneumonia 6 taking antiepileptic medications 7 others who evaluated as inappropriate by doctor in attendance

Design outcomes

Primary

Measure	Time frame
1)Clinical effect of three days later from starting of administration 2)Body temperature,amount of sputum, property of sputum,WBC,ESR,CRP of three days later from starting of administration 3)Total clinical effect of the analysis objects 4)Bacteriological effect of the analysis objects 5)The incidence of the side effects 6)Pharmacological assessment	—

Countries

Japan

Outcome results